Who We Are

Nabi Biopharmaceuticals is focused on developing a series of first and second generation products that address unmet medical needs and offer opportunities in our core business areas: nicotine addiction and gram-positive bacterial infections.

Driven by our clinical development programs, we are focused on building value and are seeking partners for our vaccine programs: NicVAX® (Nicotine Conjugate Vaccine) and PentaStaph™ (Staphylococcal Polysaccharide Conjugate and Toxoid Vaccine).  Our headquarters is located in Rockville, Maryland along with our Research and Development facility.

We are proud of what we do and thank you for your interest in our company. If you have any questions, please contact us.

Please see Company Profiile (PDF file).

Code No. 10440-00-GEN-120407